A detailed analysis of the properties of lysozyme that make it a candidate against SARS-CoV-2, or to limit the manifestations associated with SARS-CoV-2 infection, is reported in a comprehensive review by Mann and Ndung’u, which refers to its antiviral properties to prevent COVID-19-related infections, to its direct and/or immune-mediated antiviral properties, and also to its antioxidant properties [80], and references are cited herein. This evidence concerns the gene LYZ and infection.